April 30, 2026 · Journal of the American College of Radiology : JACR · DOI: 10.1016/j.jacr.2026.03.017

Shifts in Urbanicity-Based Access to Radiotracers for Neuroendocrine Tumors

Listen to this summary

The authors aimed to assess how the introduction of newer radiotracers, specifically ^68Ga-DOTATATE/DOTATOC and ^64Cu-DOTATATE, affected geographic access to radiotracers for patients with neuroendocrine tumors (NETs) compared to the traditional ^111In-pentetreotide. Their findings indicate that while patients from small or rural areas initially faced greater travel distances for gallium-based radiotracers, the introduction of copper-based radiotracers improved access and reduced travel distances, particularly for those in less urbanized regions. Overall, the study highlights the impact of radiotracer availability on patient access and treatment options for NETs.

Cindy X Yuan, Kylie C Long, Elizabeth Y Rula, Eric W Christensen

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play